Qube Research & Technologies (QRT)’s AstraZeneca AZN Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio AZN Stock Details AZN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$142K	Sell	750 -5,100	-87%	-$959K	﹤0.01%	2972
2026 Q1	$1.15M	Sell	5,850 -66,500	-92%	-$12.8M	﹤0.01%	2427
2025 Q4	$13.3M	Sell	72,350 -33,600	-32%	-$5.89M	0.01%	1153
2025 Q3	$16.3M	Sell	105,950 -28,850	-21%	-$4.37M	0.02%	1007
2025 Q2	$18.8M	Sell	134,800 -64,300	-32%	-$9.01M	0.02%	921
2025 Q1	$29.3M	Buy	199,100 +178,750	+878%	+$25.9M	0.03%	586
2024 Q4	$2.67M	Sell	20,350 -152,300	-88%	-$21.3M	﹤0.01%	1766
2024 Q3	$26.9M	Buy	172,650 +171,450	+14,288%	+$27.7M	0.04%	546
2024 Q2	$187K	Buy	+1,200	New	+$181K	﹤0.01%	2442

Other funds holding AZN

Evelyn Partners London $46.9B AUM

Investor AB Stockholm, Sweden $14.4B AUM 4.07% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Qube Research & Technologies (QRT)'s AZN Position: Q2 2026 in Review

Qube Research & Technologies (QRT) reduced its AstraZeneca (AZN) stake by 1.7% in Q2 2026, selling an estimated $1.24M and leaving 375,473 shares worth $71.2M. The position accounts for 0.07% of the portfolio, ranked #382.

Qube Research & Technologies (QRT) first reported a position in AZN in Q1 2018 and has held it in 20 quarters since. The position peaked at $75.3M in Q1 2026. 1,502 funds tracked by Wall St. Rank hold AZN as of Q2 2026.

Qube Research & Technologies (QRT) held 375,473 shares of AstraZeneca worth $71.2M as of Q2 2026.
Qube Research & Technologies (QRT) sold 6,575 AstraZeneca shares in Q2 2026, an estimated $1.24M.
AstraZeneca made up 0.07% of Qube Research & Technologies (QRT)'s portfolio in Q2 2026, its #382 holding.
Qube Research & Technologies (QRT) first reported a position in AstraZeneca in Q1 2018 and has held it in 20 quarters since.
Qube Research & Technologies (QRT)'s AstraZeneca position peaked at $75.3M in Q1 2026.
1,502 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q2 2026, filed 14 Aug 2026.